3a) This program is accredited for 0.75hr 🆓CE/#CME and is supported by an unrestricted educational grant from Amgen. It is intended for an audience of #HCPs. Follow this 🧵for credit, and follow us here for more #MedEd opportunities, always 🆓, always from the top experts!

2) The #LBCTs excerpted here were selected by 3⃣international experts on #LLT: Alan Brown MD MHA FACC FNLA @alanbrownmd, Peter P Toth MD PhD FCCP FAHA FESC FACC, & returning faculty Pam R. Taub MD FACC FASPC @PamTaubMD while onsite together at #AHA25.

1) Welcome to a new #accredited #tweetorial from @cardiomet_ce, your ONLY source for 🆓CE/#CME from expert faculty delivered wholly on #Twitter/X. We have one more report from #AHA25, & this one focuses on exciting new data on the management of #hyperlipidemia. #MedEd #cardioX

22) In summary, the #ATTR_CM landscape continues to be dynamic. We have three approved drugs and many more exciting drugs in the pipeline. Follow @cardiomet_ce for ongoing expert-led CE/#CME in this space—always 🆓!

1) Welcome to a new CE/#CME-accredited #tweetorial with updates from #AHA2025 on gene silencer therapeutics for #ATTR_CM. A couple years ago we had no specific tx for ATTR, and now our proverbial cup runneth over! #cardiotwitter #cardioX #MedEd

@heartdrsingh 17) And that's it! You just earned 0.5hr 🆓CE/#CME! Just point your 🖱️to https://t.co/tDwN8ntEsq and claim your certificate. Thanks to @heartdrsingh for teaching us! You can always learn from the experts and earn 🆓CE/#CME 🇺🇸🇬🇧🇨🇦🇪🇺at @cardiomet_ce !! #AHA25 #AHA2025

1) Welcome to a new #accredited #tweetorial from @cardiomet_ce, posted just after new, aggregated data have been presented at #AHA25 in #NOLA on the use of nasal 👃#etripamil for acute #PSVT! Our returning expert author is Narendra Singh MD @heartdrsingh, #cardiologist.

1) Welcome to a new #accredited #tweetorial from @ckd_ce and @cardiomet_ce, addressing Phase 3 data from #ESC2025 on the first major advancement in #hypertension therapy in 20 years! We're talking about #aldosterone synthase inhibitors #ASI for difficult-to-control #HTN.

2) You've already seen those data w/@PamTaubMD & u can still earn 🆓credit by checking out https://t.co/7UAKU80flQ. Now we take a look at those data through the eyes of our favorite #nephrology expert & prolific author, Edgar Lerma @edgarvlermamd 🇵🇭. #nephtwitter #MedEd #nephX

1) Welcome to a new #accredited #tweetorial from @cardiomet_ce and @ckd_ce, addressing Phase 3 data from #ESC2025 on the first major advancement in #hypertension therapy in 20 years! We're talking about #aldosterone synthase inhibitors #ASI for difficult-to-control #HTN.

29) And now you are UP TO DATE! Claim your 0.75hr 🆓CE/#CME at https://t.co/CYgI8dtcMK and FOLLOW US for more expert-authored #tweetorials right here on @onc_ce! Many thanks to @harrisoncn1 for authoring this program!

1) Welcome to a 🆕 CE/#CME-accredited tweetorial, brought to you by the expert faculty of @onc_ce! Our program concerns the foundational understanding of #myelofibrosis #MF & in particular the symptom and financial burdens of #anaemia that accompany the disease.

17) Now we invite you to point your 🖱️over to https://t.co/28P92xzLdF claim your 🆓0.5hr CE/#CME credit 🇺🇸🇨🇦🇪🇺🇬🇧! Thanks for joining us & reinforcing important lessons learned from #ESC25. Again we encourage you to view the video discussion at

1) Welcome to a new #accredited #tweetorial from your friendly gang of #cardiometabolic experts! This is a follow-up from our last post on #hyperlipidemia, still available for CE/#CME credit at https://t.co/kUEbCHNS0k. Follow this 🧵for ANOTHER 0.5hr 🆓credit!

23) That is in the (near?) future. RIGHT NOW, you can claim your 0.5hr of CE/#CME by pointing your to https://t.co/5pQ6ChfJhk. Many thanks to our expert author @Ash_Shoamanesh!

1) Welcome to a new #accredited #tweetorial from @cardiomet_ce! This tweetorial is the third of 3⃣ that addresses advances in the secondary prevention of ischemic, non-cardioembolic #stroke. Follow this 🧵for 0.5hr 🆓 CE/#CME !

1) Welcome to an update from Madrid 🇪🇸 and #ESCCongress, where your faithful @ckd_ce correspondents grabbed latest data on #aldosterone synthase inhibitors #ASIs & difficult-to-treat "resistant" #HTN. We SCORED, as new Phase 3 data were presented in a #LBCT.

Presented at #ESCCongress: In patients with an acute coronary syndrome, stopping aspirin early after PCI and using P2Y12 inhibitor monotherapy was not noninferior to dual therapy with respect to risk of death or ischemic events but did reduce bleeding events. Full NEO-MINDSET

Adrenal insufficiency is a syndrome of cortisol deficiency. This Review summarizes the pathophysiology of adrenal insufficiency and approaches to diagnosis, treatment, and prevention of adrenal crisis. https://t.co/68Td08HbKV

🚨 New #ESC/#EACTS 2025 Guidelines on #ValvularHeartDisease 🫀 Essential updates for cardiology & cardiac surgery practice. 👉 #ESC25 #ESCcongress #VHD